E.V. Verbitskiy et al.
Journal of Photochemistry & Photobiology, A: Chemistry 404 (2021) 112900
3.4. General procedure for the synthesis of 5-[4-(heteroaryl)phenyl]-
[1,2,5]oxadiazolo[3,4-b]pyrazine (7a,b) and 5-[5-(heteroaryl)thiophen-
2-yl]-[1,2,5]oxadiazolo[3,4-b]pyrazine (8a,b)
1 H), 7.83 – 7.78 (m, 2 H), 7.54 – 7.44 (m, 4 H), 7.33 (ddd, J = 7.9, 6.9,
1.2 Hz, 2 H). 13C NMR (151 MHz, DMSO-d6) δ 155.4, 154.7, 152.7,
152.2, 152.1, 140.5, 140.3, 138.4, 136.8, 131.8, 128.4, 127.8, 127.3,
126.9, 123.5, 121.1, 120.9, 110.3.
ν
(DRA, cm-1) 3093 (br. w, C–HAr),
A mixture of 5-(4-bromophenyl)-[1,2,5]oxadiazolo[3,4-b]pyrazine
(3) (277 mg, 1.0 mmol) [or 5-(5-bromothiophen-2-yl)-[1,2,5]oxadia-
zolo[3,4-b]pyrazine (5) (283 mg, 1.0 mmol)], corresponding arylbor-
onic acid 6a,b (1.2 mmol), Pd(PPh3)4 (115 mg, 10 mol %) and K3PO3
(530 mg, 2.5 mmol) was dissolved in 1,4-dioxane 15 mL. The reaction
mixture was degassed and refluxed for 15 h under an argon atmosphere.
After completion of the reaction (monitored by TLC), the reaction
mixture was cooled, filtered, and dissolved in a mixture of EtOAc and
water (1:1, 50 mL), and the organic layer was separated. The aqueous
layer was extracted with EtOAc (2 × 25 mL). The combined organic
extracts were dried with MgSO4 and the solvents evaporated. Purifica-
tion by silica gel column chromatography with CH2Cl2/hexane (1:2, v/
v) as an eluent to afford the title compounds (7 and 8).
3080 (br. w, C–HAr), 3060 (br. w, C–HAr), 3028 (br. w, C–HAr), 1599 (s,
C–CAr/C–NAr), 1567 (s, C–CAr/ C–NAr), 1533 (s, C–CAr/ C–NAr), 1449 (s,
C–CAr/ C–NAr), 1406 (s, C–CAr/ C–NAr), 837 (s, C–HAr), 749 (s, C–HAr),
724 (s, C–HAr). Calcd. for C26H15N5OS (445.50): C, 70.10; H, 3.39; N,
15.72. Found: C, 70.00; H, 3.54; N, 15.56.
4. Conclusion
In summary, four new push-pull chromophores bearing [1,2,5]oxa-
diazolo[3,4-b]pyrazine as electron-withdrawing part and amino group
as donor were designed. There electrochemical and photophysical
properties indicate that intense ICT occurs in these structures with
electrochemical gap below 2.1 eV and strong emission solvatochromism.
NLO responses were also measured by EFISH method. All experimental
and theoretical results indicate a significant increase of ICT when the
diphenylamino electro-donating group is used and when a 2,5-thieny-
lene bridge is replacing the 1,4-phenylene linker. Compound 8a, that
combines these two characteristics, exhibits a particularly high figure of
merit and appears as an interesting candidate for incorporation in a
polymeric matrix to obtain a material with the high electro-optic
coefficient.
3.5. ’-([1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl)-N,N-diphenyl-[1,1’-
biphenyl]-4-amine (7a)
Yield 375 mg (85%), dark violet solid, mp 223-224 ◦C. 1H NMR
(600 MHz, DMSO-d6) δ 9.87 (s, 1 H), 8.54–8.47 (m, 2 H), 7.99–7.94 (m,
2 H), 7.81–7.76 (m, 2 H), 7.39–7.35 (m, 4 H), 7.14–7.10 (m, 6 H),
7.08–7.05 (m, 2 H). 13C NMR (151 MHz, DMSO-d6) δ 159.4, 156.4,
152.9, 152.1, 148.4, 147.2, 144.3, 133.0, 132.1, 130.2, 128.5, 127.2,
125.2, 124.2, 122.9.
ν
(DRA, cm-1) 3062 (w, C–HAr), 3053 (w, C–HAr),
Declaration of Competing Interest
3037(w, C–HAr), 1586 (s, C–CA/C–NAr), 1561(s, C–CAr/C–NAr), 1488 (s,
C–CAr/C–NAr), 1446 (s, C–CAr/C–NAr), 822 (s, C–HAr), 797 (s, C–HAr),
753 (s, C–HAr), 697 (s, C–HAr). Calcd. for C28H19N5O (441.49): C, 76.17;
H, 4.34; N, 15.86. Found: C, 75.95; H, 4.32; N, 16.09.
The authors report no declarations of interest.
Acknowledgments
3.6. -(4’-(9H-Carbazol-9-yl)-[1,1’-biphenyl]-4-yl)-[1,2,5]oxadiazolo
VEV is grateful to the financial support for the synthetic part from the
Russian Foundation for Basic Research (Research Project No. 18-29-
23045 mk).
[3,4-b]pyrazine (7b)
Yield 338 mg (77%), red solid, mp 288-289 ◦C. 1H NMR (600 MHz,
DMSO-d6) δ 9.91 (s, 1 H), 8.63–8.57 (m, 2 H), 8.28 (dt, J = 7.8, 1.0 Hz,
2 H), 8.20–8.11 (m, 4 H), 7.84–7.78 (m, 2 H), 7.53–7.45 (m, 4 H), 7.33
(ddd, J = 7.9, 6.7, 1.3 Hz, 2 H). 13C NMR (151 MHz, DMSO-d6) δ 159.5,
156.3, 152.9, 152.2, 143.9, 140.5, 138.1, 137.8, 134.0, 130.3, 129.3,
Appendix A. Supplementary data
Supplementary material related to this article can be found, in the
128.1, 127.7, 123.5, 121.1, 120.8, 110.2.
ν
(DRA, cm-1) 3034 (w,
C–HAr), 1564 (s, C–CAr/C–NAr), 1447 (s, C–CAr/ C–NAr), 746 (s, C–HAr),
723 (s, C–HAr). Calcd. for C28H17N5O (439.48): C, 76.52; H, 3.90; N,
15.94. Found: C, 76.65; H, 3.78; N, 16.10.
References
3.7. -(5-([1,2,5]oxadiazolo[3,4-b]pyrazin-5-yl)thiophen-2-yl)-N,N-
diphenylaniline (8a)
Yield 349 mg (78%), violet solid, mp 248-249 ◦C. 1H NMR (600 MHz,
DMSO-d6) δ 9.74 (s, 1 H), 8.55 (d, J =4.2 Hz, 1 H), 7.81–7.74 (m, 2 H),
7.72 (d, J =4.2 Hz, 1 H), 7.42–7.33 (m, 4 H), 7.20–7.07 (m, 6 H),
7.01–6.95 (m, 2 H). 13C NMR (151 MHz, DMSO-d6) δ 155.5, 154.5,
153.7, 152.8, 152.0, 149.2, 146.8, 139.0, 137.0, 130.3, 127.9, 125.9,
125.6, 125.5, 124.7, 121.9.
ν
(DRA, cm-1) 3085 (w, C–HAr), 3062 (w,
C–HAr), 3035 (w, C–HAr), 1589 (s, C–CAr/ C–NAr), 1568 (s, C–CAr
/
/
C–NAr), 1488 (s, C–CAr/C–NAr), 1438 (s, C–CAr/C–NAr), 1405 (s, C–CAr
C–NAr), 833 (s, C–HAr), 751 (s, C–HAr), 694 (s, C–HAr). Calcd. for
C
26H17N5OS (447.52): C, 69.78; H, 3.83; N, 15.65. Found: C, 69.83; H,
3.77; N, 15.67.
3.8. -(5-(4-(9H-Carbazol-9-yl)phenyl)thiophen-2-yl)-[1,2,5]oxadiazolo
[3,4-b]pyrazine (8b)
Yield 321 mg (72%), red solid, mp 246-248 ◦C. 1H NMR (600 MHz,
DMSO-d6) δ 9.82 (d, J =2.1 Hz, 1 H), 8.66 (dd, J = 4.0, 2.2 Hz, 1 H), 8.28
(dt, J = 7.8, 1.1 Hz, 2 H), 8.21 – 8.15 (m, 2 H), 8.00 (dd, J = 4.0, 2.2 Hz,
7